128 related articles for article (PubMed ID: 38328845)
1. ASSESSMENT OF CIRCULATING miRNA LEVELS IN BREAST CANCER PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY.
Harashchenko О
Exp Oncol; 2024 Feb; 45(4):451-456. PubMed ID: 38328845
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women.
El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
5. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer.
Ruiz-Manriquez LM; Villarreal-Garza C; Benavides-Aguilar JA; Torres-Copado A; Isidoro-Sánchez J; Estrada-Meza C; Arvizu-Espinosa MG; Paul S; Cuevas-Diaz Duran R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373139
[TBL] [Abstract][Full Text] [Related]
7. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
[TBL] [Abstract][Full Text] [Related]
9. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
[TBL] [Abstract][Full Text] [Related]
12. Graphene Oxide-Based Highly Sensitive Assay of Circulating MicroRNAs for Early Prediction of the Response to Neoadjuvant Chemotherapy in Breast Cancer.
Li Z; Xiao H; Li J; Yang Z; Jiang J; Ji J; Peng C; He Y
Anal Chem; 2022 Nov; 94(46):16254-16264. PubMed ID: 36342865
[TBL] [Abstract][Full Text] [Related]
13. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
[TBL] [Abstract][Full Text] [Related]
14. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
16. Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer.
Gahlawat AW; Fahed L; Witte T; Schott S
Br J Cancer; 2022 Jul; 127(1):156-162. PubMed ID: 35318434
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
Ali OS; Shabayek MI; Seleem MM; Abdelaziz HG; Makhlouf DO
Clin Breast Cancer; 2018 Dec; 18(6):e1373-e1379. PubMed ID: 30143449
[TBL] [Abstract][Full Text] [Related]
18. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer.
Lukianova NY; Borikun TV; Chekhun VF
Exp Oncol; 2019 Sep; 41(3):242-247. PubMed ID: 31569928
[TBL] [Abstract][Full Text] [Related]
20. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.
Lindholm EM; Ragle Aure M; Haugen MH; Kleivi Sahlberg K; Kristensen VN; Nebdal D; Børresen-Dale AL; Lingjaerde OC; Engebraaten O
Mol Oncol; 2019 Oct; 13(10):2278-2296. PubMed ID: 31402562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
